secwatch.observer — SEC 8-K summary
======================================

Issuer:     Apimeds Pharmaceuticals US, Inc. (APUS)
CIK:        0001894525
Form:       8-K
Filed at:   2026-10-01T13:15:15+00:00
Accession:  0001213900-26-105484
Event type: leadership
Sentiment:  neutral
Materiality: 0.40
Item codes: 5.02, 9.01
LLM model:  deepseek-v4.1-flash:cloud@v2

Apimeds names Eric Sherb CFO effective Oct 1; Interim CFO Erick Frim resigned Sept 29
--------------------------------------------------------------------------------

- Erick Frim resigned as Interim CFO effective September 29, 2026; the company said the resignation was not due to any disagreement on operations, policies or practices.
- The Board appointed Eric Sherb, age 40, as CFO effective October 1, 2026, serving as principal financial officer and principal accounting officer.
- Sherb is a CPA with over 18 years of capital markets experience and founded EMS Consulting Services, LLC in January 2019, where he remains Principal.
- Employment Agreement provides a base salary of $60,000 per year; no equity awards granted at signing, and no Item 404(a) transactions or family ties to the Board or executives.
- Sherb has been fractional CFO of MindWave Innovations Inc., a wholly owned subsidiary, since February 2026; that engagement terminates with his appointment.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1894525/000121390026105484/0001213900-26-105484-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1894525/000121390026105484/ea0307269-8k_apimeds.htm
  HTML page:      https://secwatch.observer/filing/0001213900-26-105484

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer